Long Time Follow-Up Data Of First-Line Pembrolizumab For Advanced Nsclc Patients With Pd-L1 Tps Of 50% Or GreaterYuichi Tambo,Takashi Sone,Kazuhiko Shibata,Kouichi Nishi,Hiroki Shirasaki,Taro Yoneda,Tomoyuki Araya,Kazumasa Kase,Shingo Nishikawa,Hideharu Kimura,Kazuo KasaharaANNALS OF ONCOLOGY(2021)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要